Drug Manufacturing

Weight Loss Drugs Research Research and Development Regulatory Environment Approval Process Tariffs Impact Gene Therapy Weight Loss Medications Obesity Treatments Corporate Investment

3 ARTICLES

2mo ago

Roche Commits $700M to North Carolina Biologics Facility as Part of $50B U.S. Expansion

The Holly Springs site will support next-generation obesity drugs, creating 400 permanent jobs and enhancing U.S. pharmaceutical manufacturing capacity.

16 ARTICLES

2mo ago

UK Infected Blood Scandal: Inquiry to Expose Deep Failures

Drug Manufacturing

Roche Commits $700M to North Carolina Biologics Facility as Part of $50B U.S. Expansion

Roche Announces $50 Billion U.S. Investment to Expand Manufacturing and R&D

India Bans 35 Unapproved Fixed-Dose Combination Drugs

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

UK Infected Blood Scandal: Inquiry to Expose Deep Failures